<DOC>
	<DOCNO>NCT00047671</DOCNO>
	<brief_summary>This 11-week study aim determine genetic factor affect way African Americans Caucasians major depression respond antidepressant medication [ citalopram ( CelexaÂ® ) ] .</brief_summary>
	<brief_title>Ethnic Variations Antidepressant Response</brief_title>
	<detailed_description>Depressed patient vary substantially responses antidepressant . Genetic factor may account large part difference response . This study include African Americans Caucasians examine role genetic factor treatment response . Participants receive citalopram ( Celexa ) 8 week placebo 1 week . Visits occur week 11 week . A variety interview , scale , test , questionnaire use assess participant .</detailed_description>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>DSMIV criterion Major Depression AfricanAmerican Caucasian ethnic background ( parent 3 4 grandparent ) Schizophrenia , schizophreniform disorder , schizoaffective disorder , schizotypal disorder , psychotic depression , bipolar disorder Current drug abuse history drug abuse within past 6 month Unstable medical neurological condition interfere treatment depression Allergy citalopram Failure respond adequate citalopram drug trial ( 40 mg least 6 week ) Seizure disorder Pregnancy Psychotropic medication , include antidepressant neuroleptic Suicidal ideation safety issue Fluoxetine ( Prozac ) MAOIs ( Nardil , Parnate ) last 2 month Ongoing cognitive behavioral therapy intensive psychotherapy . General talk therapy acceptable</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Depressive Disorder</keyword>
</DOC>